Switching from animal-based to plant-based foods reduces risk of heart disease, diabetes, and mortality

The effects of replacing animal-based foods with plant-based alternatives on cardiometabolic health and all-cause mortality.

Psyence Group Issues Update On Psilocybin Cultivation Division, Psyence Production

Psyence Group Inc., the operator one of the world’s earliest government-licensed commercial psilocybin production facilities, today provided an update on Psyence Production—a division of Psyence

October 30, 2023

Cybin to Present at Public Ventures Discovery Day on March 19th in Dallas | Psychedelic Invest

Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation psychedelic-based

March 18, 2024

Roche declares early win for oral GLP-1 drug it bought from Carmot

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.